Le Lézard
Classified in: Health
Subject: PLW

Holganix Receives US Patent for Microbial Bionematicide Technology


Holganix was granted a patent for microbial bionematicide technology that is environmentally friendly and shown to reduce plant parasitic nematodes by over 75% in preliminary studies.

ASTON, Pa., Oct. 13, 2022 /PRNewswire-PRWeb/ -- Holganix is an agricultural biotechnology company that develops microbial products used by farmers to increase yields, boost soil health, and reduce fertilizer requirements. Today Holganix announced it has been granted a US patent (US 11,447,427 B2) for a new microbial bionematicide technology. While studies are still ongoing, preliminary results have shown a 75% reduction in plant parasitic nematodes in a lab setting and an 80% reduction in a field setting.

The new bionematicide harnesses the power of soil microbes to reduce plant parasitic nematodes including soybean cyst, corn lesion, tomato root-knot, lance, and sting nematodes. The technology utilizes three modes of action: (1) it affects the migration of nematodes to the roots, (2) it inhibits eggs from hatching, and (3) it targets plant parasitic nematodes. The new bionematicide technology is still in development and is not yet commercialized or registered with the EPA.

"With these encouraging preliminary results and intellectual property, Holganix is positioned to develop a truly unique bionematicide product for the agriculture and turf industries," explains Holganix President of Agriculture, David Stark, Ph.D. "Nematodes represent a $100 billion problem in terms of worldwide plant loss, and current solutions are often harmful to the soil and the environment. Because Holganix's technology revolves around the use of a naturally occurring, concentrated, and stabilized stack of soil microbes, this bionematicide technology will be friendly for the environment."

The patent (patent number: US 11,447,427 B2), entitled "Methods For Controlling Pathogenic Plant Nematodes and For Improving the Health and/or Performance of Ruminant Animals," was awarded to inventors, David Stark, Ph.D., President of Agriculture at Holganix LLC and Robert Neidermyer, Ph.D., Director of Soil Health at Holganix LLC.

"We are excited that the patent agency granted protection for our novel, microbial bionematicide technology and are looking forward to continuing to develop the product, registering the product through the EPA, and commercializing it for agricultural, turf, and ornamental use," explains Stark.

About Holganix:
Holganix is a manufacturer of microbial products that harness the power of soil microbes to build soil health, improve crop yield, and reduce the need for fertilizer. Holganix products allow farmers to improve their profit per acre, giving farmers the tools they need to drive both economic and environmental sustainability on the farm.

Media Contact

Kaitlyn Ersek, Holganix LLC, 1 866-563-2784, [email protected]

Twitter

 

SOURCE Holganix LLC


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: